The hematologic markers as prognostic factors in patients with resectable gastric cancer
- 26 September 2016
- journal article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 17 (3) , 359-367
Abstract
BACKGROUND: Recently, many studies have investigated the value of the hematologic markers in the prognosis of gastric cancer (GC). However, most studies only focused on the pre-operative markers. The aim of this study was to investigate the prognostiKeywords
This publication has 39 references indexed in Scilit:
- A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapyWorld Journal of Surgical Oncology, 2013
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer, 2013
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trialThe Lancet Oncology, 2013
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancerBiomarkers, 2012
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEuropean Journal of Cancer, 2011
- Evaluations of interferon‐γ/interleukin‐4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patientsJournal of Surgical Oncology, 2010
- Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratioThe American Journal of Surgery, 2010
- Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancerJournal of Surgical Oncology, 2005
- Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancerGastric Cancer, 1998